Activation of p38 MAP kinase and stress signalling in fibroblasts from the progeroid Rothmund-Thomson syndrome by Davis, Terence et al.
Activation of p38 MAP kinase and stress signalling
in fibroblasts from the progeroid Rothmund–Thomson
syndrome
Terence Davis & Hannah S. E. Tivey &
Amy J. C. Brook & Julia W. Grimstead &
Michal J. Rokicki & David Kipling
Received: 11 July 2012 /Accepted: 9 September 2012
# The Author(s) 2012. This article is published with open access at Springerlink.com
Abstract Rothmund–Thomson fibroblasts had repli-
cative lifespans and growth rates within the range for
normal fibroblasts; however, they show elevated lev-
els of the stress-associated p38 MAP kinase, sugges-
tive of stress during growth. Treatment with the p38
MAP kinase inhibitor SB203580 increased both life-
span and growth rate, as did reduction of oxidative
stress using low oxygen in some strains. At replicative
senescence p53, p21WAF1 and p16INK4A levels were
elevated, and abrogation of p53 using shRNA knock-
down allowed the cells to bypass senescence. Ectopic
expression of human telomerase allowed Rothmund–
Thomson fibroblasts to bypass senescence. However,
activated p38 was still present, and continuous growth
for some telomerised clones required either a reduc-
tion in oxidative stress or SB203580 treatment. Over-
all, the evidence suggests that replicative senescence
in Rothmund–Thomson cells resembles normal senes-
cence in that it is telomere driven and p53 dependent.
However, the lack of RECQL4 leads to enhanced
levels of stress during cell growth that may lead to
moderate levels of stress-induced premature senes-
cence. As replicative senescence is believed to un-
derlie human ageing, a moderate level of stress-
induced premature senescence and p38 activity may
play a role in the relatively mild ageing phenotype
seen in Rothmund–Thomson.
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Introduction
Rothmund–Thomson syndrome (RTS) is a rare auto-
somal recessive genetic disorder (Thomson 1936;
Rothmund 1868). The most characteristic feature is
cutaneous poikiloderma (a skin condition that consists
of areas of increased and decreased pigmentation,
prominent blood vessels or telangiectasias, and thin-
ning of the skin) that usually appears in infancy, with
red oedematous plaques and blistering occurring on
the cheeks, forehead and ears, and is most severe in
sun-exposed areas. Other features include short stat-
ure, hair greying (although rarely), alopecia, sparse
eyebrows and eyelashes, café-au-lait spots and hyper-
keratotic lesions. It can be further categorised into two
clinical subtypes: type I, which is distinguished by
poikiloderma and juvenile cataracts, and type II,
which is characterised by poikiloderma, congenital
bone defects and osteosarcoma (Larizza et al. 2010).
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However, a major distinction is the presence or ab-
sence of RECQL4 mutations (see below). Many of the
clinical features of RTS are associated with normal
ageing, and for this reason, it is classified as a prema-
ture ageing syndrome even though RTS individuals
are felt to have a normal lifespan in the absence of
cancer (Larizza et al. 2010; Jin et al. 2008; Hofer et al.
2005). Despite having been first described in 1868,
only 300 or so individuals with RTS have been de-
scribed in the literature, and relatively, little is known
about the syndrome.
RECQL4, the gene mutated in RTS Type II, enco-
des a 1208 amino acid protein that shares significant
homology with the RECQ helicases WRN and BLM
that are mutated in Werner and Bloom syndromes,
respectively (Liu 2010). It is found in both the cyto-
plasm and nucleus, and has two nuclear localisation
signal domains located in the N-terminal part of the
protein (Yin et al. 2004; Burks et al. 2007). RECQL4
is a member of the superfamily II (SFII) helicase
family (Kitao et al. 1998). It possesses 3′–5′ helicase
activity in vitro and is capable of unwinding DNA
structures that include splayed arms, bubbles and
blunt-end duplex DNA (Xu and Liu 2009).
Most mutations in RECQL4 are frame-shift, non-
sense or splicing mutations that are predicted to result
in a truncated protein (Larizza et al. 2010; Wang et al.
2003; Bachrati and Hickson 2003; Kitao et al. 1998).
It is thought that complete loss of RECQL4 is lethal in
humans as complete absence of RECQL4 is incom-
patible with cell viability (Abe et al. 2011). In addi-
tion, ectopic expression of recombinant RECQL4
proteins containing only the N-terminal 496 amino
acids in RECQL4 null cells is sufficient for cell viability
(Abe et al. 2011), and the majority of RECQL4 muta-
tions are found 3′ to amino acid 496 (Larizza et al.
2010). These data suggest that the mutant proteins found
in RTS individuals are partially active even though they
may be expressed at very low levels (Ouyang et al.
2008). Interestingly, mutations in RECQL4 have only
been found in type II RTS, and the aetiology of type I
RTS is unknown (Larizza et al. 2010).
Several attempts have been made to generate mouse
RTS models, with mixed success. Mutations in the N-
terminal domain of mouse Recql4 are embryonic le-
thal (Ichikawa et al. 2002), and deletions in the SFII
helicase domain proved to have high mortality, with
most pups not surviving beyond 2 weeks (Hoki et al.
2003). Those animals that did survive had skin
atrophy, hair graying, hair loss, short stature, bone
dysplasia, dystrophic teeth and immunological abnor-
malities, although they failed to develop poikiloderma,
bilateral cataracts or malignancies, all of which are
hallmark features observed in RTS individuals (Hoki
et al. 2003). The lack of these hallmark features may
not be surprising, however, as the very short lifespan
of these mice may leave insufficient time for their
development. These mice also did not have inflamma-
tion. Finally, a Recql4 mouse model was generated by
introducing a frame-shift resulting in Recql4 truncated
in the first half of the SFII helicase domain that
mimics the mutation seen in many RTS individuals
(Mann et al. 2005). This mouse showed hyper-
pigmented skin and developed poikiloderma reminis-
cent of that seen in RTS individuals, defects in skeletal
development and cancer pre-disposition. The Recql4
mice that survived into adulthood had normal life-
spans (Mann et al. 2005).
Features of premature ageing may be found in RTS
individuals and is seen in the RTS mouse model.
Replicative cellular senescence (Hayflick and Moor-
head 1961) has been postulated as a factor underlying
human ageing (Faragher et al. 2009; Ostler et al.
2002), and several observations suggest that senescent
cells occur in vivo and accumulate with age [reviewed
in (Faragher et al. 2009)]. Other data that provide
support for a role of replicative cellular senescence
in human ageing comes from studies of progeroid
syndromes such as Werner (WS), Hutchinson Gilford
Progeria Syndrome (HGPS) and Ataxia Telangiectasia
(AT) [reviewed in (Davis et al. 2009)]. In these syn-
dromes, fibroblasts show accelerated ageing in vitro,
leading to speculation that this may underlie some of
the accelerated features of ageing in these syndromes.
In particular, young (low population doublings) WS
fibroblasts have very short lifespans and growth rates,
together with an altered morphology reminiscent of
senescent cells, even though they are a growing popu-
lation (Davis et al. 2005a). They also show high levels
of stress-associated p38 MAP kinase activity, and it has
been demonstrated that continuous treatment with the
p38 inhibitor SB203580 normalises their replicative
lifespan and aged morphology (Davis et al. 2005a).
The MAP kinase p38 responds to and is activated
by endogenous and exogenous cellular stress (Freund
et al. 2011). p38 is involved in growth arrest in re-
sponse to the expression of oncogenes such as ras
(Wang et al. 2002; Deng et al. 2004), exogenous stress
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such as arsenite treatment or oxidative stress (Guay et
al. 1997), and in telomere-dependent senescence
(Iwasa et al. 2003): indeed, p38 defines a common
senescence signalling pathway (Iwasa et al. 2003).
p38 is important for senescence growth arrest due
to its ability to activate both the p53/p21WAF1 and
pRb/p16INK4A growth arrest pathways.
These data, together with the effects of p38 inhibi-
tion on WS fibroblast growth, suggest that activation
of p38 may be responsible for many of the senescence-
like features of WS fibroblasts, a situation known as
stress-induced premature senescence (SIPS) (Davis
and Kipling 2006; Toussaint et al. 2000) and may
underlie the accelerated ageing seen in WS individu-
als. In addition, because WS individuals have an in-
creased prevalence of inflammatory diseases such as
atherosclerosis and have high circulatory levels of
p38-inducible pro-inflammatory cytokines such as
TNFα (Yokote et al. 2004), it is possible that p38
activity may also underlie the inflammatory features
seen in WS (Davis and Kipling 2006).
Although WS is a segmental progeria and many
RTS individuals have been described as showing pre-
mature ageing, it is unknown whether they share an
underlying causal mechanism. However, because RTS
shares many clinical features with WS, it is possible
that premature cellular ageing and p38 activation may
also underlie some of the features seen in RTS. A
possible inducer of p38 activation is genomic instabil-
ity, and consistent with this hypothesis is the observa-
tion that karyotype analysis of RTS primary
fibroblasts and lymphocytes reveals an unusually high
incidence of chromosomal rearrangements, transloca-
tions and deletions (Der Kaloustian et al. 1990; Lindor
et al. 1996; Orstavik et al. 1994). In addition, some
RTS fibroblasts show increased sensitivity to ionising
radiation (Smith and Paterson 1982; Kerr et al. 1996;
Varughese et al. 1992) and UV radiation (Vasseur et al.
1999; Shinya et al. 1993). Together with a requirement
for RECQL4 in DNA replication (Hoki et al. 2003;
Mann et al. 2005) and telomere maintenance (Ghosh et
al. 2012), these observations suggest that loss of
RECQL4 may adversely impact upon DNA replication
and repair, and in turn affect cellular growth and life-
span. However, few studies have been undertaken to
date on the growth characteristics of RTS fibroblasts.
To address the impact of loss of human RECQL4
function on cell behaviour, we have therefore analysed
multiple aspects of the RTS cellular phenotype, with
particular reference to those relevant to replicative
senescence and stress signalling, using primary fibro-
blasts from RTS individuals. We compare these data
(including growth rates, replicative lifespan, the role
of p53 and telomerase in determining replicative life-
span, and the effects of alleviating oxidative stress)
with our previous published data on primary WS
fibroblasts and discuss how the differences in cellular
phenotype that we observe may explain key difference
in the clinical presentation of these two progeroid
syndromes.
Methods
Cells and cell culture
Primary dermal fibroblasts derived from biopsies of
human tissue from three RTS individuals (AG18371,
AG18375 and AG17524) and one normal 12-year-old
individual (AG16409) were obtained from the Coriell
Cell Repository (Camden, NJ). Of these, AG18371
obtained from a 12-year old is homozygous for a
RECQL4 gene deletion (g.2746del11); AG17524
obtained from a 4-year old has a compound heterozy-
gote for a substitution (g.2626G>A) resulting in alter-
native splicing and a 2-bp deletion (g.4644delAT) that
in turn causes a frame-shift; and AG18375 obtained
from a 22-year old has a compound heterozygote for
two RECQL4 muta t i on s (g .2626G>A and
g.2886delT). All the above alleles result in protein-
truncation 3′ to the nuclear localisation signal. To
avoid confusion when referring to cell strains, a suffix
has been added to the strain code, i.e. AG18371(RTS)
for Rothmund–Thomson Syndrome or AG16409(N)
for Normal cells.
Cells were grown in Earle’s modified Eagle medium
(EMEM) [1× MEM, 1 mM sodium pyruvate, 1× vita-
mins, 1× essential amino acids (all from Gibco, Life
Technologies, Paisley, UK), 0.22 % (w/v) NaHCO3,
2 mM glutamine (both from Invitrogen, Life Technolo-
gies, Paisley, UK), 1× non-essential amino acids,
10,000 U/ml penicillin, 10 mg/ml streptomycin (all from
Sigma, Poole, UK), 10 % (v/v) FCS (Autogen Bioclear,
Salisbury, UK)] at 37 °C in an atmosphere containing
20 % O2 and 5 % CO2 with the medium changed
daily as previously described (Davis et al. 2005a).
For growth experiments using low oxygen, the O2
tension was reduced to 3 %. Population doublings
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(PDs) were calculated according to the formula:
PD ¼ log Nt=Noð Þ= log 2, where Nt is number of
cells counted and No is number of cells seeded.
Cells were passaged when attaining approximately
90 % confluency. Initial growth rates were calcu-
lated over the first 30 days of culture.
Inhibitor treatments
For SB203580 treatment, cells were fed daily with
EMEM supplemented with 2.5 μM SB203580 (Tocris
Chemical Co., Bristol, UK), and for controls, an
equivalent volume of the drug solvent (DMSO) was
added to the medium; 2.5 μM is within the range used
routinely for studying the effects of SB203580 on p38
activity in cell biological systems (Wang et al. 2002;
Haq et al. 2002; Iwasa et al. 2003). We have previous-
ly shown that this concentration effectively inhibits
p38 but does not significantly inhibit the related
JNK1/2 kinases (Bagley et al. 2010).
The protein kinase A (PKA) inhibitor H89 was
obtained from Tocris Chemical Co. (Bristol, UK) as
the hydrogen chloride salt. H89 dissolved in DMSO
was added to culture dishes to a final concentration of
10 μM (Shiryaev et al. 2011).
BrdU incorporation assays
DNA synthesis was assayed by labelling cells in the
presence of 10 μM bromodeoxyuridine (BrdU) for
1 h, following which BrdU incorporation was detected
by immunoperoxidase as previously described (Davis
et al. 2003). The proportion of BrdU-positive cells was
assessed in a total count of 500 cells. Assays were
done in triplicate.
Detection of senescence-associated β-galactosidase
activity
Endogenous mammalian senescence-associated β-
galactosidase activity (SAβ-gal) was assessed histo-
chemically as described (Davis et al. 2003).
Retroviral gene transfer
For ectopic expression of telomerase pBABE-hTERT,
an amphotropic retrovirus expressing the catalytic
protein subunit of human telomerase hTERT was
constructed by cloning the EcoRI insert of pGRN121
(a gift from Geron Corp, Menlo Park, CA, USA) into
pBABE-puro (Morgenstern and Land 1990) and pack-
aged in ψCRIP cells. For control infections, pBABE-
puro vectors packaged in ψCRIP cells were used.
A shRNA targeted to p53 was expressed from
pMKO.1PS (kindly donated by William Hahn, Har-
vard Medical School) packaged in ψCRIP (Moffat et
al. 2006). The p53 21-bp short hairpin sequence is
5′-GACTCCAGTGGTAATCTACTG-3 ′. Empty
pMKO.1PS packaged in ψCRIP cells was used
as the puromycin control.
Retroviral transduction was carried out as described
previously (Davis et al. 2003). Fibroblasts for retrovi-
ral infection were plated in 6-cm Petri dishes 24 h
prior to infection at a seeding density of 6,000 cells/
cm2. Prior to infection, cells were treated with poly-
brene at 8 μg/ml for 1 h. Cells were infected by
treating with 4 ml filtered retroviral supernatants for
24 h, before replacing the supernatant with 5 ml of
fresh EMEM without selection. Forty-eight hours after
the start of infection, fibroblast cultures were passed
into EMEM containing puromycin (2.5 μg/ml), at
serial dilutions of 1:5, 1:10, 1:100 and 1:250, and
observed for colony development. Alternatively, fibro-
blasts were passaged into fresh dishes with selective
medium and cultured as described above to produce
bulk cultures of mixed clones.
Detection of telomerase activity
Telomerase activity in whole cell extracts was detected
using the telomeric repeat amplification protocol
(TRAP) assay as described previously (Davis et al.
2005b). The cell line 293 provided a telomerase-
positive control. Reaction products were separated on
non-denaturing 10 % polyacrylamide gels and visual-
ized by Sybr Gold staining and fluorimaging on a
STORM system using blue fluorescence mode (AP
Biotech).
Immunoblot analysis
Protein samples were prepared in lysis buffer containing
the phosphatase inhibitors NaF and Na3VO4, separated
on 12 % sodium dodecylsulphate/polyacrylamide elec-
trophoresis gels, electroblotted to Immobilon-P polyvi-
nylidene difluoride membrane (Millipore, Watford, UK)
and antibodies applied as described previously (Davis et
al. 2005a, b). The antibodies used were: mouse
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monoclonal anti-p53 (DO-1) (Calbiochem, Merck,
UK); mouse monoclonal anti-p21WAF1 (6B6), rab-
bit anti-p16INK4 (both from Becton Dickinson, Ox-
ford, UK); mouse monoclonal anti-HSP27 (G31),
rabbit polyclonal anti-phospho(Ser82)-HSP27, anti-
p38, anti-phospho(Thr180/Tyr182)-p38, anti-MK2
(all from Cell Signalling, New England Biolabs,
Hitchin, UK); and rabbit polyclonal anti-actin (Sig-
ma, Poole, UK). An enhanced chemiluminescence
kit (GE Healthcare, Amersham, UK) was used for
visualization using HRP-coupled goat secondary
antibodies.
Immunofluorescence microscopy
Actin staining for immunofluorescence microscopy was
performed as described (Davis et al. 2005a). Briefly, the
cells were plated into 35-mm plastic dishes in EMEM
and allowed to settle for 48 h. The cells were then washed
in phosphate-buffered saline (PBS), fixed in 3.7 % para-
formaldehyde for 20 min and permeabilised with 0.1 %
Triton-X100 for 20 min. F-actin was detected using
fluorescein isothiocyanate (FITC)-conjugated phalloidin
(33 μg/ml) (Sigma, Poole, UK), diluted 1:50 in PBS for
30 min in the dark, followed by washing in PBS.
Results
Lifespan, growth rate and morphology of primary RTS
fibroblasts
Three strains of primary RTS dermal fibroblasts were
grown to M1 senescence, and the effects of SB203580
or culture under low oxygen were determined and
compared to normal fibroblasts grown in parallel
(Fig. 1). Growth rate, cellular lifespan and mor-
phology were determined.
The normal strain of dermal fibroblasts, AG16409
(N), had a replicative lifespan of 54.3 PDs that increased
to 61.9 PDs with SB203580 treatment and decreased to
51.7 PDs under low oxygen (Table 1). In contrast, the
replicative lifespans of all three RTS strains were less
than for the control AG16409(N) fibroblasts, irrespec-
tive of treatment. The three RTS strains had a mean
replicative lifespan of 25.5±14.0 PDs under control
conditions, and all showed an increase in lifespan when
treated with the p38 inhibitor SB203580. The overall
lifespan (33.0±16.3 PDs) of the RTS strains in the
presence of SB203580 corresponds to a lifespan exten-
sion of 33 %. Growth under reduced (3 %) oxygen
conditions has a more variable effect on RTS fibroblast
lifespan, and although the mean lifespan was increased
to 28.3±11.5 PDs (Table 1), this is largely the result of a
strong response by AG17524(RTS).
The mean initial growth rate (determined over
the first 30 days of growth) for RTS cells was
0.31±0.08 PDs/day. This increased to 0.51±0.17
and 0.38±0.17 PDs/day for SB203580 treatment
and under low oxygen, respectively. The initial
growth rate increased in all RTS strains under all
treatments with the exception of AG18375(RTS)
under low oxygen (Table 1). At early passage,
RTS cells had BrdU labelling indexes (LIs) rang-
ing from 23.1±1.9 % for AG18375(RTS) to 28.5±
1.9 % for AG18371(RTS), versus 31.8±2.1 for
AG16409(N) cells. For each strain, the BrdU LI
increased with SB203580 treatment or when grown
under conditions of low oxygen reflecting the in-
creased initial growth rate seen for each cell strain,
with the exception of AG18375(RTS) cells grown
under low oxygen (data not shown).
The RTS strains showed a consistent morphology
when young (i.e. at low PD), as illustrated by the
AG18371(RTS) cells shown in Fig. 2a. These were
mostly small in size and resembled AG16409(N) cells
(Fig. S1, see Online resource 1). When stained with
FITC-phalloidin most of the young AG18371(RTS)
cells were small, with few F-actin stress fibres visible,
and only a few cells had an enlarged morphology
(Fig. 2b). SB203580 treatment or growth under condi-
tions of reduced oxygen tension had little effect upon the
morphology and stress-fibre phenotype of the AG18371
(RTS) cells (Fig. 2c, d). Similar results were seen for the
AG18735(RTS), AG17524(RTS) and AG16409(N)
strains (Fig. S1, see Online resource 1).
At M1 senescence, the AG18371(RTS) cells had
an enlarged and irregular morphology (Fig. 2e)
with extensive F-actin stress fibres (Fig. 2f), very
low BrdU LI (1.2±0.5 % or less) and a high
proportion of SAβ-gal staining (see dark patches
in Fig. 2g). Similar results were seen for the
AG18375(RTS) and AG16409(N) cells (Fig. S1,
see Online resource 1). AG17524(RTS) cells at
M1 senescence were slightly atypical, in that they
had the enlarged morphology, low BrdU LI and
high SAβ-gal staining as seen for the other RTS
strains, but did not show extensive F-actin stress
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fibres (Fig. S1, see Online resource 1). Note that,
although we have described here a single NDF, we
have provided growth data for a further six NDF
strains (Table S1, See Online resource 2).
Table 1 Lifespan and growth
rates of normal and RTS
fibroblasts
n/a not applicable
aCells grown in EMEM (control),
in EMEM+2.5 μM SB203580 or
in EMEM under 3 % oxygen
bThe percent increase is deter-
mined by lifespan achieved in
SB203580, or under 3 % oxy-
gen, divided by control lifespan
cValue determined for the
growth during the first 30 days
Strain Growth
conditiona
Lifespan
achieved (PDs)
% lifespan
increaseb
Growth rate
(PDs/day)c
AG16409(N) Control 54.3 n/a 0.41
SB203580 61.9 11.4 0.65
3 % oxygen 51.7 −4.8 0.55
AG18371(RTS) Control 37.9 n/a 0.41
SB203580 43.2 14.0 0.70
3 % oxygen 36.0 −5.1 0.52
AG18375(RTS) Control 10.3 n/a 0.24
SB203580 14.3 38.8 0.37
3 % oxygen 12.0 16.5 0.22
AG17524(RTS) Control 28.3 n/a 0.31
SB203580 41.4 46.3 0.46
3 % oxygen 36.7 29.7 0.41
Fig. 1 Growth of Roth-
mund–Thomson syndrome
and normal fibroblasts.
Fibroblasts were grown in
standard EMEM with no
supplementation (open cir-
cle), with continual daily
supplementation with
SB203580 (solid circle),
under 3 % oxygen (open
triangle). Growth measured
as PDs versus days
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Abrogation of p53 function extends the cellular life
span of RTS fibroblasts
To determine the role of p53 in the regulation of
RTS fibroblast lifespan, pre-senescent AG18371
(RTS) fibroblasts at PD 36 (BrdU LI of 3.4±
0.8 %) were infected with amphotropic retroviral
vectors encoding a puromycin resistance (puro)
gene alone, or both puro and an shRNA to p53.
Analysis of puromycin-resistant colonies [designat-
ed (RTS)puro and (RTS)p53, respectively] began 2
to 3 weeks after infection.
Cells expressing puro alone ceased proliferating
within the first 2 weeks and entered a senescent-like
state with clones of a maximum of two cells (1 PD)
(Fig. 3). The AG18371(RTS)puro cells at this stage
appeared essentially identical to uninfected AG18371
(RTS) cells at M1 (not shown). In contrast, expression
of the p53 shRNA resulted in evasion of senescence
and generated rapidly growing colonies. In AG18371
(RTS)p53 cells at about 15 PDs post-infection (13 PDs
post M1), p53 protein levels were very low compared
to cells at M1, showing that the shRNA had success-
fully abrogated p53 levels (Fig. 4a). At 15 PDs post-
infection, the AG18371(RTS)p53 cells are approaching
Mint (see below).
Young AG18371(RTS)p53 cells (<10 PD post-
infection) had a small morphology (not shown) and a
BrdU LI of 25.2 %±1.8 %. Eventually, more than
120 days post-infection, net growth ceased (Fig. 3)
and the cells entered a state similar to a second
senescence-like state termed Mint that has been de-
scribed previously for p53-abrogated human fibro-
blasts (Bond et al. 1999). The Mint-like state for the
three AG18371(RTS)p53 clones was reached with a
final cell count equivalent to 17.35±0.77 PDs post-
infection (Fig. 3); this compares to 1.0 PD for the five
puro control clones (p<4×10−9; Student’s t test).
A similar but less dramatic lifespan extension was
seen for AG17524(RTS) cells (Fig. 3); when
infected at PD 26.5, the puromycin-resistant con-
trol clones managed an average post-infection life-
span of 1.31±0.67 PDs before reaching M1,
compared to 6 .52 ± 1.82 PDs for shRNA-
expressing AG17524(RTS)p53 cells at Mint (p<
2.9×10−8; Student’s t test). The short lifespan
and thus limited cell numbers available for
AG18375(RTS) precluded analysis of this strain.
Fig. 2 Morphological analysis of AG18371(RTS) fibroblasts.
a–d Cycling cells, e–g cells at M1. BF are cells under phase
contrast, phalloidin are cells stained with phalloidin-FITC,
SAβ-gal are cells stained for senescence-associated β-
galactosidase activity. Bar0100 μm
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Expression of cell cycle proteins in RTS and normal
fibroblasts
Molecular profiling of the normal fibroblasts and two of
the RTS strains was undertaken by immunoblot analy-
sis; limited cell numbers for AG18375(RTS) precluded
analysis of this third RTS strain. Cycling RTS cells
showed low levels of the cyclin-dependent kinase inhib-
itors (CdkIs) p21WAF1 and p16INK4A that increased
markedly when the cells reached M1 (Fig. 4a). This
contrasts with the normal cells where the level of
p16INK4A did not increase in AG16409(N) cells at M1,
whereas there was a small increase in p21WAF1 (Fig. 4a).
The levels of the CdkIs appeared to be higher in cycling
AG18371(RTS) cells than in cycling AG17524(RTS) or
AG16409(N) cells; however, the CdkI levels were low
in all the cycling cell populations (Fig. 4b). Treatment
with SB203580 or growth at low oxygen did not affect
the levels of the CdkIs in cycling AG18371(RTS) but
appeared to reduce p16INK4A in cycling AG17524(RTS)
and AG16409(N) cells (Fig. 4b). SB203580 treatment
or growth under low oxygen had only a small effect on
the levels of p21WAF1.
p53 protein was present at low levels in cycling RTS
and AG16409(N) cells. This increased in AG16409(N) at
M1 senescence, and even more markedly so in RTS cells
at M1 (Fig. 4a). Interestingly, despite loss of p53 expres-
sion in AG18371(RTS)p53 cells, the level of the p53
target p21WAF1 actually increased in the AG18371
(RTS)p53 cells, presumably due to p53-independent up-
regulation. In contrast, levels of p16INK4A in AG18371
(RTS)p53 cells remained the same as seen at M1. Insuffi-
cient numbers of cells were available for a similar anal-
ysis of p53 and CdkI expression in AG17524(RTS)p53.
RTS fibroblasts have activated p38 signalling
Activated (phosphorylated) p38 was detected by im-
munoblot assay in both AG18371(RTS) and AG17524
(RTS) young primary fibroblasts but not in young
AG16409(N) cells (Fig. 5a). This level of p38 phos-
phorylation increased further at M1 senescence in
AG18371(RTS) cells but decreased in AG17524
(RTS) cells at M1 even when taking into account
sample under-loading (Fig. 5b). This observation cor-
relates with the lack of stress fibres seen in AG17524
(RTS) but not AG18371(RTS) cells at M1 (Fig. S1,
see Online resource 1, Fig. 2f). Interestingly, p38 was
activated further when young RTS cells were grown in
the p38 inhibitor SB203580 (Fig. 5a).
The immediate p38 downstream target MK2 showed
activation in young cycling RTS cells, as demonstrated
by the presence of a doublet (Fig. 5a, arrow), and activa-
tion was also detected, albeit to a lesser extent, in
AG16409(N) cells. As expected, treatment of all cells
with SB203580 prevented MK2 activation, as shown by
the absence of a doublet (Fig. 5a). However, growth of
cells under low oxygen had little effect on MK2
activation.
HSP27, the downstream target of MK2, was phos-
phorylated in both AG18371(RTS) and AG17524
(RTS) fibroblasts and, to a lesser extent, in AG16409
Fig. 3 Extension of cellular
lifespan of Rothmund–
Thomson cells following
abrogation of p53. Bar chart
showing lifespan of puro
and shp53 expressing
clones. Statistical test is
Student’s t test
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(N) cells (Fig. 5a). In contrast to MK2, HSP27 phos-
phorylation was not reduced by SB203580 in young
RTS cells, although it was in AG16409(N) cells
(Fig. 5a, C), suggesting that some degree of MK2-
independent phosphorylation of HSP27 is occurring
specifically in RTS cells. Protein kinase A (PKA)
has been implicated in F-actin rearrangements via
MK5 induced HSP27 phosphorylation (Shiryaev et
al. 2011). To determine whether the retention of
HSP27 phosphorylation in the presence of
SB203580 in RTS cells was PKA-dependent, we
used the PKA inhibitor H89. Treatment of 16409
(N) and AG18371(RTS) cells with H89 for 2 h
had a pronounced effect upon cellular morphology
(not shown) but did not alter the phosphorylation
status of HSP27 (Fig. 5c). As treatment of cells
with H89 for 30 min is sufficient to block PKA
activity and down-regulate phosphorylated HSP27
(Shiryaev et al. 2011), this suggests that HSP27
phosphorylation in RTS cells appears not be due
to either the p38 or PKA pathways.
Fig. 4 Immunoblot analysis of cell cycle proteins in RTS and
normal cells. a Lysates were prepared from cycling cells (Cy),
senescent cells (M1) and cycling shp53 cells (p53). b Lysates were
prepared from cells grown in EMEM+0.1 % (v/v) DMSO (D),
EMEM+2.5 μM SB203580 (SB), cells grown under low oxygen
(LO2). Expression levels were compared for various proteins as
indicated: S and L indicate short and long exposures. Actin was
used as a loading control. Note that the p21 band for AG16409(N)
LO2 in b has been cut and pasted from the same gel and exposure
as the other p21 bands (indicated by vertical black line) but has
otherwise been treated exactly as for the rest of the gel
Fig. 5 Analysis of stress kinases in RTS and normal cells. a
Lysates were prepared from cells grown in EMEM+0.1 % (v/v)
DMSO (D), EMEM+2.5 μM SB203580 (SB), cells grown
under low oxygen (LO2). b Lysates were prepared from cycling
cells (Cy) and senescent cells (M1). c Lysates were prepared
from cells grown for 3 days in EMEM+0.1 % (v/v) DMSO.
Cells grown for 3 days in EMEM+0.1 % (v/v) DMSO followed
by 10 μMH89 for 2 h (D/H), cells grown for 3 days in EMEM+
2.5 μM SB203580 (SB), cells grown for 3 days in EMEM+
2.5 μM SB203580 followed by 10 μMH89 for 2 h (SB/H).
Expression levels were compared for various proteins as indi-
cated; pp38 and pHSP27 are the phosphorylated (activated)
versions of p38 and HSP27, respectively. Samples were equal-
ised for p38 expression (a and b) or HSP27 (c). In a, the arrow
marks activated MK2
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Extension of the lifespan of RTS cells by ectopic
hTERT expression
To assess the role of telomere erosion in regulating RTS
cellular lifespan, early passage RTS cells were infected
with retroviruses expressing puromycin resistance and
hTERT (the catalytic protein subunit of telomerase), or
puromycin resistance only. Drug-resistant colonies were
selected and designated as (RTS)tert and (RTS)puro. Telo-
merase activity was assessed using the TRAP assay
(Fig. 6a). AG16409(N) cells were used as a control,
and AG16409(N)tert cells reached >100 PDs, double
the lifespan seen in AG16409(N)puro cells (Fig. 6b),
and have continued to divide. Similar observations of
the immortalisation of normal fibroblasts by ectopic
hTERT expression have been reported numerous times
previously.
For AG18375(RTS), cells were infected at 1 PD and
the two AG18375(RTS)puro clones managed 10.5 and
13.3 PDs before reaching M1 (Fig. 6c). The AG18375
(RTS)tert clones 1 and 3 achieved greater than 55 PDs
and showed little sign of senescing; indeed, these lines
Fig. 6 Extension of cellular lifespan of AG16409(N) and RTS
cells following ectopic expression of hTERT. a TRAP assay
showing telomerase activity: heat0samples heat-treated (+) at
85 °C for 10 min to destroy the telomerase activity. b Growth in
PDs versus days for AG16409(N) cells. c Growth in PDs versus
days for AG18375(RTS) cells. d Growth in PDs versus days for
AG18371(RTS)tert clones grown under 20 % or 3 % oxygen. e
Growth in PDs versus days for AG18371(RTS)tert clones grown
with or without SB203580 (the open circles and open squares
are the data from d). f Immunoblot showing activated p38 in
AG18371(RTS)tert1 cells; the controls are AG16409(N)tert cells
and AG16409(N)tert cells treated with 30 μM anisomycin (Sig-
ma, Poole, UK) for 45 min to activate p38. g, h SAβ-gal stained
AG18371(RTS)tert1 cells at 52 PDs grown under 20 % oxygen
or at 71 PDs grown under 3 % oxygen, respectively; bar0
100 μm
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are still growing today. The expression of telomerase
activity was confirmed using TRAP assay (Fig. 6a).
For AG18371(RTS), the three puro-only control
clones achieved between 25 and 35 PDs and as
expected were TRAP negative (Fig. 6a and data not
shown). For AG18371(RTS)tert, two clones expressing
telomerase were selected for long-term culture. The
first clone, AG18371(RTS)tert1, underwent two phases
of almost stationary growth and ceased dividing at 52
PDs post-infection (Fig. 6c) at which time the cells
showed an enlarged morphology with high staining
for SAβ-gal (see dark patches in Fig. 6g) and a BrdU
LI of <5 %, suggesting that these were senescent cells.
The AG18371(RTS)tert1 cells have activated p38 com-
pared to AG16409(N)tert cells, similar to AG18371
(RTS) primary cells (Fig. 6f). The second clone,
AG18371(RTS)tert2, managed >70 PDs and is still
dividing (Fig. 6d); however, this clone also underwent
two phases of almost stationary growth during this
time with the cells having high SAβ-gal staining and
a low BrdU LI (data not shown).
Both AG18371(RTS)tert clones were transferred to
low-oxygen conditions (3 %) at early passage (∼18
PDs) and, after a brief period of relatively slow
growth, maintained a high growth rate and have now
achieved >81 PDs for AG18371(RTS)tert1 and >100
PDs for AG18371(RTS)tert2 suggestive of immortal-
isation (Fig. 6d). The AG18371(RTS)tert1 cells under
low oxygen at 71 PDs resembled young AG18371
(RTS) cells having a small morphology and very low
SAβ-gal staining (Fig. 6h) and a high BrdU LI. Final-
ly, transferring AG18371(RTS) clones 1 and 2 to
medium containing SB203580 at 2.5 μM just prior
to the first slow growth phase resulted in rapidly
growing cultures (Fig. 6e).
Discussion
Progeroid syndromes are widely used as models for
some aspects of human ageing, the best-studied being
WS, AT and HGPS (Martin et al. 1999; Hofer et al.
2005; Davis et al. 2009; Navarro et al. 2006; Kipling
et al. 2004). Fibroblasts from WS, AT and HGPS
individuals show accelerated ageing in vitro, and this
may underlie some of the accelerated features of
whole body ageing in these syndromes, with WS and
AT fibroblasts having very abbreviated lifespans and
HGPS fibroblasts showing high levels of apoptosis
(Tollefsbol and Cohen 1984; Tchirkov and Lansdorp
2003; Bridger and Kill 2004). Although RTS individ-
uals show some features of premature ageing, RTS is
less well studied and relatively little has been reported
to date on the growth characteristics of RTS fibro-
blasts, and it is unknown whether any aspects of
accelerated cell ageing occur in this syndrome that
might contribute to the premature ageing of these
individuals. For this reason, this study sought to ex-
amine multiple aspects of the RTS cellular growth
phenotype relevant to cellular ageing, including
growth rates, replicative lifespan, the role of p53 and
telomerase in determining replicative lifespan, and the
effects of alleviating oxidative stress.
A role for RECQL4 in DNA replication has been
suggested, as the primary interacting proteins are in
human chromatin, including the DNA replicating fac-
tors MCM10, MCM2-7, CDC45 and GINS (Xu et al.
2009). The RECQL4-MCM replication complex is re-
quired only during the G1 and S phases of the cell cycle,
and RECQL4 has been shown in a Xenopusmodel to be
important for the initiation of DNA synthesis via the
recruitment of DNA polymerase α (Sangrithi et al.
2005; Matsuno et al. 2006). In addition, the circadian
protein TIMELESS and its partner protein TIPIN, which
are important for replication progression, cohesion es-
tablishment and stress response, are also found com-
plexed with RECQL4. A role for RECQL4 in DNA
replication initiation has been implicated from studies
using mouse embryonic fibroblasts (MEFs) from the
Recql4 SFII helicase deficient mice; these grew more
slowly than normal MEFs and had reduced DNA repli-
cation (Mann et al. 2005; Hoki et al. 2003). Together,
these data suggest that RECQL4 has a unique role in the
establishment of DNA replication that is not seen in
other RECQ proteins (Liu 2010), although the details
of this role remain unclear. Despite these prior findings,
we find that primary fibroblasts from RTS individu-
als do not show a dramatic reduction in growth rate.
We find that RTS fibroblasts had growth rates that
varied between 0.24 and 0.41 PDs/day (Table 1),
whilst normal fibroblasts had growth rates varying
between 0.15 and 0.41 PDs/day (Table S1, see
Online resource 2). This suggests that any defect in
DNA replication in human RTS cells is relatively
subtle and insufficient to have a major impact on
overall population growth rate.
Young (low PD) RTS cells show activated stress-
associated p38 MAP kinase, together with activated
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MK2 and phosphorylated HSP27 compared to normal
fibroblasts [this work and (Davis et al. 2005a; Davis
and Kipling 2009; Davis et al. 2007)], yet strongly
resemble normal fibroblasts in morphology and do not
have extensive F-actin stress fibres. The lack of p38
activation and stress fibres is seen both in the NDF
strain from a young individual used here and NDF
strains from older individuals used previously (Davis
and Kipling 2009). This differs markedly from young
WS cells, which although showing activated p38 and
phosphorylated HSP27 furthermore show extensive
stress fibres (Davis et al. 2005a). WS cells have very
short replicative lifespans (Tollefsbol and Cohen
1984) and much reduced growth rates (Davis et al.
2005a; Faragher et al. 1993), and it has been argued
that lack of the WRN protein leads to stress-induced
premature senescence (SIPS) as a result of replicative
stress (Davis and Kipling 2006). Treatment of WS
fibroblasts using the p38 inhibitor SB203580 corrects
these phenotypes and extends the replicative lifespan
to within the range seen for normal fibroblasts (Davis
et al. 2005a). Although the growth rates of RTS fibro-
blasts were also increased with SB203580, the degree
of increase was not significantly more than is seen for
normal fibroblasts when treated with SB203580
(Table S1, see Online resource 2). Taken together,
our data suggest that while lack of RECQL4 results
in increased levels of stress signalling (as judged by
elevated phospho p38 in cycling RTS cells) in com-
parison to normal fibroblasts, it is nevertheless at a
level that does not significantly impact on cell growth
rates. In contrast, WS cells show an elevated level of
stress signalling that is sufficient to impact on cell
growth rates, as judged by the major effect of
SB203580 on WS cell growth rates (see Table 2).
Oxidative stress is known to play a role in SIPS via
its activation of p38 MAP kinase signalling (Huot et al.
1997). This does not appear to be the case for AG18371
(RTS) cells, however, since reduced oxidative stress
(growth in reduced oxygen) had little effect on the
growth rates or replicative lifespan of this strain and
no effect on stress kinase activation. However, reduced
oxygen did have an effect on AG17524(RTS) cells,
resulting in an increased cellular lifespan and a reduc-
tion in p38 activation. The differences in the RTS strains
may be due to the different specific RECQL4 mutations
in each strain or the broader difference in genetic back-
ground. These data contrast with that for WS fibroblasts
where low oxygen increased cellular lifespan in all
strains studied, although it did not affect the aged mor-
phology or the phosphorylation of HSP27 (Kashino et
al. 2003; Davis et al. 2007).
Strain AG18371(RTS) illustrates that it is possible
to have the clinical RTS phenotype together with
fibroblasts that show active stress signalling that does
not respond to a reduction in oxidative stress. This
suggests that loss of RECQL4 function may directly
lead to activation of stress signalling, with the possi-
bility that oxidative stress may synergise with this on
some genetic backgrounds. Possible causes of stress in
RTS cells as a direct consequence of RECQL4 func-
tion include problems occurring during chromosome
segregation and/or DNA replication; RECQL4 forms a
stable complex with the ubiquitin ligases UBR1 and
UBR2, which are involved in the N-end rule pathway
shown to be essential for correct chromosome segrega-
tion (Rao et al. 2001; Yin et al. 2004), and has a known
role in DNA replication (Xu et al. 2009). In addition,
stress may result from genomic instability as manifested
by a high incidence of chromosomal rearrangements,
translocations and deletions in RTS cells (Orstavik et al.
1994; Lindor et al. 1996; Der Kaloustian et al. 1990).
The average replicative lifespan for three strains of
RTS fibroblasts (25.5±14.0 PDs) is less than the nor-
mal fibroblasts used in this study (54.3 PDs). Addi-
tional data from our previous work on an additional
seven normal fibroblast strains, grown under the same
conditions used in this study, show that they had a
mean replicative lifespan of 38.8±10.5 PDs (Table S1,
see Online resource 2). Although overall in this small
dataset (n03 RTS strains) RTS fibroblasts do not show
a statistically significant reduction of replicative life-
span compared to normal fibroblasts, it should be
noted that three out of eight of the normal fibroblast
strains used previously had replicative lifespans in
excess of 45 PDs, and none had lifespans less than
24 PDs (this work and Table S1, see Online resource
2). In contrast, of the RTS strains, one had a lifespan of
approximately 10 PDs and none had a lifespan greater
than 38 PDs. Thus, although the reduction in average
lifespan of RTS fibroblasts did not reach statistical
significance, nevertheless the data are consistent with
the RTS strains clustering in the lower part of the
range of fibroblast replicative lifespans.
RTS fibroblasts at M1 resembled senescent normal
fibroblasts with regard to morphology, the demonstrated
low BrdU LIs, high staining for SAβ-gal activity, and
elevated levels of the CdkIs p21WAF1 and p16INK4A
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compared to growing cells (Bond et al. 1999; Dulic et al.
2000). p53 levels were higher in senescent RTS cells
compared to matched young cycling cells, paralleling
similar observations reported previously for human
IMR90 fibroblasts (Chen et al. 2004) and sheep fibro-
blasts (Davis et al. 2005b), and contrasts with the lack of
increase in p53 protein levels reported for normal hu-
man HCA2 fibroblasts and WS fibroblasts (Davis et al.
2003; Webley et al. 2000). Overall, RTS cells at senes-
cence strongly resemble fibroblasts from other sources,
and any differences may simply reflect donor or tissue-
specific effects. One curious observation is the lack of F-
actin stress fibres and p38 MAP kinase activation in
AG17524(RTS) cells at M1, which contrasts with the
high levels of activated p38 seen in AG18371(RTS) or
WS fibroblasts at M1 (Davis et al. 2005a). Elevated p38
activity and F-actin stress fibres have been found in
several strains of human fibroblasts at M1 (Davis et al.
2005a; Iwasa et al. 2003), and activated p38 results in
production of F-actin stress fibres (Huot et al. 1997).
The elevation of p53 and p21WAF1 at M1 sug-
gests a causal role in senescence in RTS cells.
Indeed, experimental abrogation of p53 using
shRNA expression caused RTS fibroblasts to bypass
M1. Similar to what has been reported for normal
fibroblasts, abrogation of p53 function does not
result in complete immortalisation of RTS cells
but rather causes a finite extension of cellular
lifespan and eventual entry into a downstream state
of non-growth termed Mint (Bond et al. 1999).
AG18371(RTS)p53 cells reach Mint after approxi-
mately 18 PDs, a lifespan extension similar to that
seen in normal and WS cells (Davis et al. 2003;
Bond et al. 1999).
However, contrary to that seen in normal or WS
fibroblasts (Davis et al. 2003; Bond et al. 1999; Dulic
et al. 2000), the levels of p21WAF1 increased in the
AG18371p53 cells. Whilst p21WAF1 can be up-
regulated as normal cells approach Mint in a p53-
independent manner, its level is still low compared
with normal cells at M1 (Bond et al. 1999), suggesting
a different p53-independent process in AG18371
(RTS)p53 cells. As p21WAF1 can be up-regulated in
IMR90 cells by oxidative stress even when p53 is
abrogated using siRNA (Zdanov et al. 2007), it may
be that AG18371(RTS)p53 cells have increased stress
as they bypass M1, although it is not known whether
there is increased oxidative stress in AG18371
(RTS)p53 cells. Alternatively, the known chromosomal
instability seen in RTS cells (Lindor et al. 1996;
Orstavik et al. 1994; Der Kaloustian et al. 1990) may
result in increased stress as AG18371(RTS)p53 cells
bypass M1 leading to up-regulation of p21WAF1, albeit
this is speculation.
Recently, it has been reported that RECQL4 is
required for telomere maintenance as, although the
Table 2 Comparison between normal, RTS and WS fibroblasts
Condition Normal RTS WSa
Lifespan 25–55 PDs normal range 10–37 PDsb within normal range 15–25 PDs reducedc
Growth rate 0.15–0.41 PDs/day normal range 0.24–0.41 PDs/day within normal
rangeb
0.06–0.14 PDs/day
reducedc
Effect of SB20580 Increased lifespan, increased
growth rate
Increases within normal rangeb Significantly increasedc
Cell morphology Normal, mostly small with few
stress fibres
Similar to normal Many enlarged cells with
F-actin stress fibres
Effect of SB203580
on morphology
Almost no effect Almost no effect Cells resemble low PD
normal cells
Cells at M1 Enlarged with F-actin stress fibres AG17524(RTS) enlarged no stress
fibres, others as normal cells
As normal cells
Phospho p38 level in low
PD cells
Not detected Detectable: low in AG18371
compared to M1,
low in AG17524 and not seen at M1
Detectable: as high as seen
at M1
aData adapted from Davis et al. (2005a)
b Not significantly different from normal
c Significantly different from normal
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frequency of telomere fusion and breakage was not
elevated in RTS compared to normal cells, the fre-
quency of fragile telomeres was increased in
AG18371(RTS) fibroblasts, and in HeLa and U2OS
cells depleted in RECQL4 using shRNA constructs
(Ghosh et al. 2012). In addition, RECQL4 localises
to telomeres at S phase and has weak D-loop resolving
activity, at least in vitro. These data, together with the
putative role for RECQL4 in DNA replication (Liu
2010), suggest that RECQL4 is involved in telomere
maintenance during DNA replication, even though the
growth rates of RTS cells are within the normal range
(this work). As ectopic expression of telomerase in
RTS cells successfully produced telomerase activity
and resulted in immortalised RTS cells lines, either
RECQL4 is dispensable for telomerase activity, or the
low levels of RECQL4 thought to be found in RTS
cell strains (Ouyang et al. 2008) are sufficient for
telomerase activity and telomere maintenance in the
presence of high telomerase levels.
The ability of telomerase to extend the lifespan of
RTS cells was limited and cell strain dependent. In
AG18375(RTS), telomerase expression extended the
lifespan well beyond the puro-only controls. For
AG18371(RTS), however, telomerase expression was
insufficient to immortalise some clones, or resulted in
poorly growing clones, unless the cells were grown
under conditions of low oxygen or in the presence of
p38 inhibitors. This may be due to lack of RECQL4
resulting in increased stress when telomerase is ectop-
ically expressed, since RECQL4 is involved in telo-
mere maintenance (Ghosh et al. 2012). This stress (or
its effect on cell lifespan) appears to be reduced under
low-oxygen conditions or when the p38-signalling
pathway is inhibited.
Overall, the evidence suggests that lack of RECQL4
leads to enhanced levels of stress in RTS cells compared
to normal cells, possibly as a result of the chromosomal
instability seen in RTS and/or the reduced DNA replica-
tion. This stress is transduced by the p38-signalling
pathway and leads to SIPS. However, as RTS cells do
not have major differences in replicative lifespan, growth
rates or cellular morphology compared to normal fibro-
blasts (see Table 2 for summary), this SIPS is only high
enough to haveminor effects on the replicative capability
of RTS cells. In contrast, in WS a high level of SIPS is
supported by the much reduced growth rates, replicative
lifespan and the aged morphology seen in WS fibro-
blasts, features that are all corrected using the p38
inhibitor SB203580 (Table 2). This lower level of stress
in RTS cells is further supported by the low level of p38
activation in young AG18371(RTS) cells compared to
cells at M1, contrasting with the high level of activated
p38 seen in both young and senescentWS cells (Table 2).
A moderate level of stress is also supported by the
reduced sensitivity of RTS cells to a wide range of
genotoxic agents compared to WS cells (Jin et al.
2008), and reports showing little sensitivity of RTS cells
to such agents (Cabral et al. 2008; Werner et al. 2006).
That the low level of SIPS in RTS cells does not lead
to major proliferative defects in fibroblasts does not
preclude a role of SIPS in RTS. Indeed, the progeroid
features seen in RTS are mild compared toWS (Hofer et
al. 2005) and parallel the lower level of SIPS seen in
RTS cells in culture. In contrast, the much reduced life-
span and high levels of SIPS seen in WS fibroblasts
parallel the more severe progeroid features for WS that
include the inflammatory conditions of atherosclerosis
and type II diabetes (Davis and Kipling 2006). If repli-
cative lifespan of fibroblasts in vitro does reflect on
whole body ageing rates, it may be that the mild proge-
roid features seen in RTS result, in part, from a small
stress-induced reduction in replicative lifespan that is
not easily detectable due to the large variations seen in
both RTS and normal fibroblasts, given the unavoidably
small number of RTS strains that have been studied to
date. It is of course possible that the low level of SIPS
and p38 activity seen in RTS fibroblasts is due to RTS
not really being a bona fide progeroid syndrome: in-
deed, the data in this paper may be interpreted as support
for that conclusion.
One of the problems in interpreting the data in this
work is that the RTS phenotpyes are somewhat subtle,
possibly due to RECQL4 being an essential protein
and thus the mutations being hypomorphic with resid-
ual RECQL4 activity and not nulls. In addition, the
lack of isogenic lines for direct comparison leads to
genetic background issues. These problems may be
alleviated to some extent using RNAi knockdown of
RECQL4 RNA in control fibroblasts lines. However,
RNAi is not without its own problems namely that the
knockdown has variable penetration, thus possibly
leaving detectable levels of wild-type RECQL4 that
would be difficult to compare to the low levels of
mutant proteins found in RTS fibroblasts. Even so,
future studies should examine phenotypes in isogenic
cells to help substantiate the findings in this study and
to attempt to minimize genetic background effects.
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